latest news releases from the newsroom
TASER International, Inc.
Study Finds Prolonged Exposure from a TASER Electronic Control Device Has No Abnormal Respiratory Effects on Human Subjects
SCOTTSDALE, Ariz., Feb. 7, 2007 (PRIME NEWSWIRE) -- TASER International, Inc. (Nasdaq:TASR), a market leader in advanced personal protection devices announced today that a landmark study by Dr. Jeffrey Ho, a physician in the Department of Emergency Medicine at Hennepin County Medical Center (Minneapolis, MN) who led a group of physicians including Dr. Donald M. Dawes of Lompoc District Hospital (Lompoc, CA) and Dr. Laura L. Bultman of Northern California Kaiser Permanente (Sacramento, CA) and other researchers from around the country concluded that prolonged exposure to a conducted energy weapon "did not impair respiratory parameters in this population group of volunteers."
Chelsea Therapeutics Elects Kevan Clemens, Ph.D., as Chairman of the Board
CHARLOTTE, N.C., Feb. 7, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced today that its Board of Directors elected Kevan Clemens, Ph.D., Chairman of the Board at its meeting on Tuesday, February 6, 2007. Dr. Clemens succeeds Dr. Michael Weiser who has held the post since the company's inception in 2004 and who will continue to serve as a member of Chelsea's Board of Directors.